Analyst Ratings for Pacira Pharmaceuticals (PCRX)
PCRX Rating Summary
PCRX Price Target Summary
- Highest: $36.50 (H.C. Wainwright)
- Lowest: $25.00 (Barclays)
- Average: $32.17
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$32.17 (-11.5%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Avg. $ Target:
$32.17 (-11.5%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2026 | H.C. Wainwright | Douglas Tsao | Downgrade | Neutral (Buy) |
36.50 (N/A) |
36.39 (36.34) |
-0.14% | Details |
| 10/8/2026 | Oppenheimer | Les Sulewski | Downgrade | Perform (Outperform) |
N/A (N/A) |
25.20 (36.34) |
44.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
